Professur für Pharmakologie und Toxikologie
Präsidium der Justus-Liebig-Universität Gießen » Fachbereiche » Fachbereich 10 - Veterinärmedizin » Dekanat Fachbereich 10 - Veterinärmedizin » Institut für Pharmakologie und Toxikologie
Type of organisation: Professorship
Projects
- Structure-based drug development of virus-selective HBV/HDV entry inhibitors by virtual screening in collaboration with the company ChemSpace
01/07/2024 - 28/02/2026
Hessian Ministry of Higher Education, Research, Science and the Arts (HMWK) - Philipp Schwartz-Stipendium der Alexander von Humboldt-Stiftung/Verlängerung Prof. Dr. Emre Karakus
01/08/2021 - 31/07/2022
Alexander von Humboldt Foundation (AvH) - Stipendium Emre Karakus - Scholar Rescue Fund
01/08/2018 - 31/07/2019
University of Giessen (JLU) - Kooperationsvertrag Pharmakovigilanz – Instrument zur Überwachung und Betreuung von Tierarzneimitteln
17/05/2018 - 17/05/2020
Federal Office of Consumer Protection and Food Safety (BVL) - SFB 1021 TP B08* - RNA-Viren: Metabolismus viraler RNA, Immunantwort der Wirtszellen und virale Pathogenese - Teilprojekt: Interaktionen des Hepatitis-D-Virus (HDV) mit seinem Helfervirus (HBV) und seinem Rezeptor NTCP in einem in vitro Infektionsmodell
01/01/2017 - 31/03/2021
German Research Foundation (DFG)
Publications
- Role of the Sodium-Dependent Organic Anion Transporter (SOAT/SLC10A6) in Physiology and Pathophysiology (2023)Organic Cation Transporter I and Na+/taurocholate Co-Transporting Polypeptide are Involved in Retrorsine- and Senecionine-Induced Hepatotoxicity in HepaRG cells (2022)
Wannowius, M; Karakus, E; Aktürk, Z; et al. - The Rauischholzhausen Transport Colloquium: membrane proteins from structure to function (2023)
Geyer, J; Hofmann, E; Schmitt, L - IFITM3 Interacts with the HBV/HDV Receptor NTCP and Modulates Virus Entry and Infection (2022))
Palatini, M; Müller, SF; Kirstgen, M; et al. - Role of the Steroid Sulfate Uptake Transporter Soat (Slc10a6) in Adipose Tissue and 3T3-L1 Adipocytes (2022)
Karakus, E; Schmid, A; Leiting, S; et al. - The orally available sodium/taurocholate co-transporting polypeptide inhibitor A2342 blocks hepatitis B and D entry in vitro (2022
Bonn, B; Strängberg, E; Uzelac, I; et al. - The orally available sodium/taurocholate co-transporting polypeptide inhibitor A2342 blocks hepatitus B and D entry in vitro
Bonn, B; Strängberg, E; Uzelac, I; et al.